What amount sold does JUVENTAS THERAPEUTICS INC report in Form D filings?

The latest linked filings report $13.7M sold across 3 identified offering(s). 2 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was JUVENTAS THERAPEUTICS INC's most recent SEC filing?

JUVENTAS THERAPEUTICS INC's most recent Form D filing was on 2017-10-04.

How many investors does JUVENTAS THERAPEUTICS INC have?

The most recent Form D filing lists 46 investor(s).

What type of securities does JUVENTAS THERAPEUTICS INC offer?

JUVENTAS THERAPEUTICS INC's SEC Form D filings indicate debt offerings.

JUVENTAS THERAPEUTICS INC

CIK: 0001448342·Biotechnology·CLEVELAND, OH·Corporation

Reported Sold

$13,697,614

Total Filings

Identified Offerings

Last Filed

Oct 4, 2017

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 2 unlinked amendments excluded.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 4, 2017Form D — New notice

Reported sold: $1,311,202 · Target: $6,000,000

Rule 506(b)·46 investors

May 19, 2015Form D — New notice

Reported sold: $7,386,412 · Target: $7,386,412

Rule 506(b)·37 investors

Nov 20, 2013Form D — New notice

Reported sold: $5,000,000 · Target: $5,000,000

Rule 506(b)·45 investors

Aug 8, 2012Form D/A — Amendment

Reported sold: $22,060,000 · Target: $22,060,000

Rule 506·35 investors

Changed: Reported amount sold, Offering target, Reported investors

Feb 3, 2012Form D/A — Amendment

Reported sold: $12,000,000 · Target: $20,000,000

No verified predecessor available.

Rule 506·34 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

40%

Latest reported sold across 3 identified offerings

$13,697,614

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

2 unlinked amendments excluded.

Key People

Roger Newton

Related Person

Appears on 4 filings

Rahul Aras

Related Person

Appears on 4 filings

Linda Tufts

Related Person

Appears on 4 filings

Marc Penn

Related Person

Appears on 3 filings

Matthew Pollman

Related Person

Appears on 3 filings

Somu Subramaniam

Related Person

Appears on 3 filings

George Arida

Related Person

Appears on 3 filings

Suzette Dutch

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 4, 2017	New	$6,000,000	$1,311,202	46
May 19, 2015	New	$7,386,412	$7,386,412	37
Nov 20, 2013	New	$5,000,000	$5,000,000	45
Aug 8, 2012	Amendment	$22,060,000	$22,060,000	35
Feb 3, 2012	Amendment	$20,000,000	$12,000,000	34

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Autology, Inc.

Biotechnology

Offering target: $5,100,000

Filed Sep 30, 2026